Veverimer treats metabolic acidosis by binding and eliminating hydrochloric acid from the gastrointestinal tract without introducing unwanted sodium or potassium.
Transfusion risk reduction appeared greater in nondialysis than dialysis patients taking roxadustat, data show.
In a study of dialysis patients, higher interleukin 6 levels correlated with higher Agatston calcium scores and mortality risk.
More research is needed on diabetes-dependent eGFR decline, according to investigators.
A study of stable dialysis patients receiving sucroferric oxyhydroxide found no significant changes in hemoglobin, ferritin level, and transferrin saturation.
In a study, patients with kidney failure due to urinary tract cancers had an increased mortality risk and decreased access to kidney transplantation if they had active malignancy at the start of dialysis.
Study findings suggest the benefits of continuing ACEi or ARB therapy outweigh the risks in CKD patients with an eGFR less than 30 mL/min/1.73 m2.
Hyperkalemia, hypomagnesemia, and hyperparathyroidism commonly persist after kidney transplant surgery.
Adjuvant platinum-based chemotherapy for upper tract urothelial carcinoma within 90-days of nephroureterectomy improves disease-free and metastasis-free survival compared with surveillance, a study found.